The hypoxia-inducible factor (HIF) activates the expression of genes that contain a hypoxia response element (HRE). The alpha subunits of the HIF transcription factors are degraded by proteasomal pathways during normoxia, but are stabilized under hypoxic conditions. The von Hippel-Lindau protein (pVHL) mediates the ubiquitination and rapid degradation of HIF-α (including HIF-1α and HIF-2α). Post-translational hydroxylation of a proline residue in the oxygen dependent degradation (ODD) domain of HIF-α is required for the interaction between HIF and VHL. It has previously been established that cobalt mimics hypoxia and causes accumulation of HIF-1α and HIF-2α. However, little is known about the mechanism by which this occurs. In an earlier study, we demonstrated that cobalt binds directly to the ODD domain of HIF-2α. Here we provide the first evidence that cobalt inhibits pVHL binding to HIF-α even when HIF-α is hydroxylated. Deletion of 17 amino acids within the ODD domain of HIF-2α that are required for pVHL binding prevented the binding of cobalt and stabilized HIF-2α during normoxia. These findings show that cobalt mimics hypoxia, at least in part, by occupying the VHL-binding domain of HIF-α and thereby preventing the degradation of HIF-α.
Introduction
Hypoxia is a critical stimulus in many physiological and disease states (1) . Cells respond to hypoxia by regulating the expression of a number of genes, including erythropoietin, vascular endothelial growth factor and various glycolytic enzymes (2, 3, 4 and 5) . This regulation is mediated in part by transcription factors of the hypoxia-inducible factor (HIF) family (6) . HIF-1α and HIF-2α are basic helix-loop-helix PAS domain (bHLH-PAS) proteins (7) that form a heterodimer with the aryl hydrocarbon nuclear receptor translocator (ARNT) protein. Previous studies have shown that HIF-1α protein accumulates rapidly during hypoxia without a significant increase in HIF-1α mRNA levels (8) . HIF-2α, which is also known as endothelial PAS domain protein-1 (EPAS1), shares close sequence and structural homology with HIF-1α (9) . Like HIF-1α, the levels of HIF-2α protein are low during normoxia and accumulate when cells are exposed to hypoxia, proteasomal inhibitors, transition metals (e.g. cobalt), iron chelators, or reducing agents (10) . During normoxia, the HIF-α (HIF-1α and HIF-2α are referred to here simply as HIF-α, except where noted otherwise) proteins are continuously degraded by a ubiquitin-and proteasome-dependent pathway. Detailed studies of HIF-α proteins revealed a 200 amino acid sequence, called the oxygen-dependent degradation domain (ODD), which is responsible for its degradation in the presence of oxygen (11, 12) . The von Hippel-Lindau (pVHL) protein, a tumor suppressor protein, mediates the ubiquitination and degradation of HIF-α by binding to the ODD domain under conditions of normoxia (13, 14) . Recent findings revealed that pVHL-mediated degradation requires hydroxylation of specific proline residues within the ODD (15, 16, 17, and 18) . The hydroxylation of these proline residues may be critical 4 for regulating the HIF levels and therefore transcription of downstream hypoxia-responsive genes.
It has been well documented that cobalt, a transition metal, mimics hypoxia by causing the stabilization of HIF-α. However, the biochemical mechanism by which cobalt stabilizes HIF-α remains unknown. A recent model suggested that the hydroxylation of HIF-. LV PHGLDWHG E\ D group of HIF-specific hydroxylases and that cobalt can inactivate the enzymes by occupying iron-bind site on the proline hydroxylases (18) . We previously reported that HIF-2α binds cobalt in vitro and that the cobalt-binding site overlaps with the pVHL-binding site on HIF-2α (19) .
Here we show that cobalt inhibits the interaction between pVHL and hydroxylated HIF-α and that cobalt inhibits the hydroxylation of a key proline residue within the ODD domain of HIF-2α. This is the first report that cobalt stabilizes cellular HIF-2α by occupying the VHL-binding domain. 
Materials and methods

Cell
.
Binding Assays. HIF-VHL binding assays were performed as described by Cockman et al (21) .
Briefly, 35 S-labeled HIF-α and pVHL were generated in TNT reticulocyte lysates (Promega, Madison, WI), as described. Proteins were then mixed in binding buffer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 0.5% Igepal) in the presence or absence of transition metals at 4°C for 1 hr.
Samples were then subjected to immunoprecipitation with an anti-HA antibody and analyzed by SDS-PAGE followed by autoradiography.
In vitro degradation assay. 35 S-labeled proteins (1 l) were added to the following reaction: 30
of ubiquitin (Sigma), 5 l of 10×ATP-regenerating system (20 mM Tris, pH 7.5,10 mM ATP, 10 mM magnesium acetate, 300 mM creatine phosphate, 0.5 mg/ml creatine phosphokinase), and water for a final volume of 50 µl. Each reaction was incubated at 30°C, then stopped by the addition of SDS-PAGE loading buffer at the indicated times. The labeled proteins were analyzed by SDS-PAGE followed by autoradiography.
HIF-2α In vitro cobalt binding experiment
Fifty l of HisBind Resin (Novagen) was charged with 1 ml of 50 mM CoCl 2. The charged resin was then washed and suspended in binding buffer (20mM Tris HCl, pH 7.4, and 500 mM NaCl). peptide is shown in Fig. 3A . The control peptide (adrenocorticotropic hormone fragment 18-39, ACTH), and the matrix 6-aza-2 thiothymine (ATT) were from Sigma-Aldrich.
Results
The oxygen-dependent proteolytic destruction of HIF-α is mediated by the von Hippel-Lindau protein (pVHL), which is an E3 ubiquitin ligase (13) . We next examined the effects of iron chelators and cobalt on the HIF-VHL interaction. HIF-1α
and HIF-2α were translated in reticulocyte lysate in the presence of iron (100 µM FeCl 2 ), which leads to proline hydroxylation of HIF-α (15). The translation products and HA-VHL were added to the binding buffer. In some cases, cobalt (100 µM CoCl 2 ) or the iron chelator (DFO 100 µM)
was also added to the binding buffer. Results from these experiments showed that the addition of cobalt (100 µM) greatly reduced the interaction between hydroxylated HIF-α and pVHL, whereas DFO had little effect ( Fig. 2A and 2B) . We next performed a series of experiments to determine the optimal concentration of cobalt required to inhibit the HIF-VHL interaction. To do this, we used in vitro translation to generate 35 S-methionine-labeled and hydroxylated HIF-1α
and HIF-2α in the presence of iron (100 µM FeCl 2 ). We then added various concentrations of CoCl 2 to the binding reactions. We found that cobalt inhibited the interaction between HIF-α and pVHL in a concentration-dependent manner and that the maximal inhibition occurred at 100 µM CoCl 2 ( Figures 2C and 2D ). Western blot analysis revealed that the same concentration of cobalt was required to stabilize HIF-2α in PC12 cells ( Figure 2D ; lower panel). These findings show that the level of cobalt required to inhibit the HIF-VHL interaction in vitro are similar to the concentration needed to stabilize HIF-2α within PC12 cells. These results suggest that iron chelators stabilize HIF by inhibiting iron-mediated hydroxylation of the proline residue of HIF.
In contrast, cobalt not only inhibits hydroxylation, but also directly inhibits the HIF-VHL interaction.
Experiments were next performed to determine the mechanism by which cobalt inhibits the HIF-VHL interaction. We previously reported that HIF-2α binds to cobalt in vitro and that cobalt and VHL bind to the same site within the ODD (18) . The 17 amino acid cobalt-binding region 9 contains three glutamic acid residues (E) and three aspartic acid residues (D) ( Figure 3A) . The carboxyl side groups of these acidic amino acids provide possible sites for cobalt binding. When HIF-2α was mutated by removing this 17 amino acid fragment ( Figure 3A) , the resulting ODD -mutant had a prolonged half-life, as determined by in vitro degradation experiments ( Figure 3B ).
Moreover, the pVHL binding activity was abolished in the ODD -HIF-. SURWHLQ )LJXUH &
The ODD -mutant HIF-.DOVRlacked cobalt-binding activity ( Figure 3D ). These data strongly suggest that cobalt competes with pVHL for binding to HIF-α. To obtain direct evidence that cobalt binds to HIF-α, we next used matrix-assisted laser desorption time-of-flight (MALDI-TOF) to analyze the interaction of cobalt and a synthetic peptide that consisted of the deleted amino acid sequence shown in Figure 3A (amino acids 523-539 of HIF-2α). We found that this peptide binds directly to cobalt, whereas a control peptide (ACTH) that also contained five acidic amino acids did not bind to cobalt (Figure 4 ). This confirms that cobalt binds directly to a specific amino acid sequence within the ODD of HIF-α.
Discussion
The most recent model for oxygen sensing suggests that iron-mediated hydroxylation occurs via a group of HIF-specific proline hydroxylases ( Figure 5A ) (18) . It was suggested that these hydroxylases have an iron binding center and that iron is critical for its enzymatic activity. M. This is far below the concentrations of cobalt required to inhibit binding of hydroxylated HIF-α to VHL (50 to 100 M). Thus, it is likely that cobalt interferes with multiple steps of the HIF-α degradation process (see Figure 5B) . When added to the in vitro translation reaction, it is likely that cobalt prevents hydroxylation of HIF-α by binding to either HIF-specific proline hydroxylases or HIF-α LWVHOI:KHQcobalt was added to the binding reaction, it could still bind to hydroxylated HIF-α WRSUHvent the interaction between HIF and VHL.
The present studies were carried out in vitro, and do not necessarily reflect how cobalt functions within cells. One possible model to explain how cobalt could stabilize HIF-α in cells is illustrated in Figure 5B . Cobalt may occupy the iron center of a HIF-specific proline hydroxylase, thereby inactivating the enzyme. Even if a subset of HIF-α did undergo hydroxylation, hydroxylated HIF-α could still bind to cobalt. Cobalt could thereby prevent the interaction between pVHL and hydroxylated HIF-α, which would prevent subsequent ubiquitination and degradation of HIF-α. Clearly, further studies will be needed to test this and other hypotheses, and to characterize the effects of cobalt in vivo.
Because the HIF-α transcription factor plays a critical role in the cellular response to changes in oxygen levels, it is not surprising that cells have evolved multiple mechanisms to regulate its activity. Three residues have been reported to be hydroxylated under normoxic conditions, including P402, P564 and N803 (15, 16, 17, 23) . HIF-α may become oxidized (hydroxylated) at multiple sites under normoxic conditions to regulate its stability and activity. We have demonstrated that cobalt inhibits hydroxylation and pVHL binding of HIF-α at the P564 site. In future studies, it will be important to determine whether cobalt similarly regulates HIF-α at the other two hydroxylation sites.
15 Reactions were incubated at 30°C for 60 min. HIF-VHL binding reactions were performed in binding buffer by mixing modified HIF-2α and HA-VHL, as described in Materials and
Figure Legends
Methods. The interactions were detected by anti-HA immunoprecipitation and analyzed by SDS-PAGE followed by autoradiography. 
